No Data
Chordia Therapeutics Enhances Transparency With Earnings Transcript
The TSE Growth Market Index rebounds, with a stronger sense of stalemate in the afternoon but generally remains firm.
Tokyo Stock Exchange Growth Market Index 807.74 +10.04 / Volume 0.1 billion 46.52 million shares / Trading value 81.9 billion yen. Tokyo Stock Exchange Growth Market 250 Index 631.91 +8.54 / Volume 0.1 billion 1 million shares / Trading value 66.7 billion yen. In today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index rebounded. The number of advancing issues was 342, declining issues was 199, unchanged was 45. In the U.S. market on the 18th, the Dow Jones Industrial Average rose 36.86 points to 43,275.91.
Chordia Therapeutics, WACUL, etc.
<190A> Chordia Therapeutics Co., Ltd., a shareholding of JAFCO Group Co., Ltd., the percentage held decreased from 5.74% to 4.53% with a reporting obligation arising on 10th October 2024. <4173> WACUL Co., Ltd., a shareholding of JAFCO Group Co., Ltd., the percentage held decreased from 5.55% to 4.47% with a reporting obligation arising on 10th October 2024.
Insider decrases its stake in Chordia Therapeutics(190A.JP) to 10.95%
On Oct 18, 京都大学イノベーションキャピタル株式会社 submitted the Change Report to Ministry of Finance. The report shows that 京都大学イノベーションキャピタル株式会社 decreased their holdings in $Chordia Therapeutics(190A.JP)$, with
Insider decrases its stake in Chordia Therapeutics(190A.JP) to 4.53%
On Oct 18, ジャフコ グループ株式会社 submitted the Change Report to Ministry of Finance. The report shows that ジャフコ グループ株式会社 decreased their holdings in $Chordia Therapeutics(190A.JP)$, with their joint
Insider decrases its stake in Chordia Therapeutics(190A.JP) to 5.74%
On Oct 16, ジャフコ グループ株式会社 submitted the Change Report to Ministry of Finance. The report shows that ジャフコ グループ株式会社 decreased their holdings in $Chordia Therapeutics(190A.JP)$, with their joint
No Data
No Data